PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsnocardia infections
MeSH D009617 - nocardia infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D000193:Actinomycetales infections
$
Success rate
D009617: 
Nocardia infections
$
Success rate
D008271:Mycetoma
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaSulfamethoxazole, Trimethoprim Cotrim  1985-05-16   
Sulfamethoxazole, Trimethoprim Cotrim D.s  1985-03-18   
Sulfamethoxazole, Trimethoprim Sulfamethoxazole Trimethoprim  1991-10-31   
Glenmark PharmaceuticalsSulfamethoxazole, Trimethoprim Sulfamethoxazole Trimethoprim  2010-12-22   
MylanSulfamethoxazole, Trimethoprim Sulfamethoxazole Trimethoprim  2017-08-30   
RochePhenazopyridine, Sulfamethoxazole Azo Gantanol  1987-09-10   
Sulfamethoxazole Gantanol  1982-01-01   
Lupin ResearchSulfamethoxazole, Trimethoprim Sulfamethoxazole Trimethoprim  2021-01-05   
AlpharmaSulfamethoxazole, Trimethoprim Trimeth/sulfa  1988-05-23   
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
No data
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Roche
Eli Lilly
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use